INDOLENT LYMPHOMA

Clinical trials for INDOLENT LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new INDOLENT LYMPHOMA trials appear

Sign up with your email to follow new studies for INDOLENT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 3 Not yet finished but already full! 1 Terminated 1

Targeted drug combo shows promise in blood cancer transplant study

Disease control Terminated

This study tested whether adding the targeted drug inotuzumab ozogamicin before and after a stem cell transplant could help control leukemia and lymphoma. It included 15 people aged 12 to 75 with certain blood cancers. The study was stopped early, but researchers looked at safety…

Matched conditions: INDOLENT LYMPHOMA

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Jun 27, 2026 12:07 UTC

INDOLENT LYMPHOMA

Get alerted when new INDOLENT LYMPHOMA trials appear

Targeted drug combo shows promise in blood cancer transplant study